Company: HYEX
Filing Date: 2025-04-22
Form Type: 10-K/A
Source: 0001096906-25-000553
Chunk: 83

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-04-22
Form: 10-K/A
Chunk 83
---
 in operations     |  -83,923 |
| Converted during the year ended December 31, 2023 |  -38,172 |
| Balance, December 31, 2023                        | $154,150 |
| Issued during the year ended December 31, 2024    |        - |
| Derivative liabilities debt discount              |        - |
| Change in fair value recognized in operations     |  471,270 |
| Converted during the year ended December 31, 2024 |        - |
| Balance, December 31, 2024                        | $625,420 |

F-24

NOTE 9 – INCOME TAXES

The effective income tax rate for the year ended December 31, 2024 and 2023 differs from the U.S. Federal statutory rate due to the following:

|                                   |     | December 
     2024 |     | December 
     2023 |
| Federal statutory income tax rate |     | $231,810 |     | $678,297 |
| Change in valuation allowance     |     | -231,810 |     | -678,297 |
|                                   |     |       $- |     |       $- |

The components of the deferred tax assets and liabilities at December 31, 2024 and 2023 are as follows:

|                                          |     | December 
     2024 |     | December 
     2023 |
| Long-term deferred tax assets:           |     |          |     |          |
| Federal net operating loss carryforwards |     | $231,810 |     | $678,297 |
| Valuation allowance                      |     | -231,810 |     | -678,297 |
| Net long-term deferred tax assets        |     |       $- |     |       $- |

NOTE 10 – STOCKHOLDERS’ EQUITY Authorized Stock The Company has authorized 75,000,000common shares with a par value of $ 0.001per share. Each common share entitles the holder to one vote on any matter on which action of the stockholders of the corporation is sought. During February 2017, the Company increased the authorized number of shares to 500,000,000. Also, the Company increased the authorized preferred stock to 75,000,000shares and designated 25,000,000shares of preferred stock to Series A Convertible Preferred Stock. During January 2018, the Company increased